HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity

Journal of NeuroVirology

Volumn 19, Issue 3, 2013, Pages 274-279

  Iannetta, Marco ^a   Bellizzi, Anna ^a   Lo Menzo, Sara ^a   Anzivino, Elena ^a,b   D'Abramo, Alessandra ^a   Oliva, Alessandra ^a   D'Agostino, Claudia ^a   D'Ettorre, Gabriella ^a   Pietropaolo, Valeria ^a   Vullo, Vincenzo ^a   Ciardi, Maria Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HIV; Immune activation; IRIS; JCV NCCR; PML

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENFUVIRTIDE; MEFLOQUINE; METHYLPREDNISOLONE; MIRTAZAPINE; RALTEGRAVIR; RITONAVIR PLUS TIPRANAVIR; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; ATAXIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; DYSARTHRIA; DYSPHAGIA; EXPANDED DISABILITY STATUS SCALE; GENE REARRANGEMENT; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; LONGITUDINAL STUDY; LYMPHOCYTE ACTIVATION; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REGULATOR GENE; VIREMIA; VIRUS DETECTION; VIRUS LOAD;

ADRENAL CORTEX HORMONES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; COINFECTION; FATAL OUTCOME; GENE REARRANGEMENT; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MEFLOQUINE; MIANSERIN; MIDDLE AGED;

JC POLYOMAVIRUS;

EID: 84879801099     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0167-9     Document Type: Article

References (25)

1. Agostini HT, Deckhut A, Jobes DV, Girones R, Schlunck G, Prost MG, Frias C, Pérez-Trallero E, Ryschkewitsch CF, Stoner GL (2001) Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol 82:1221-1231
2. Bellizzi A, Nardis C, Anzivino E, Rodìo D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V (2012) Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol 18:1-11
3. Biogen Idec (2012) Study to explore the effect of mefloquine in subjects with progressive multifocal leukoencephalopathy (PML). ClinicalTrials.gov website. Available: http://clinicaltrials.gov/ct2/show/NCT00746941. Accessed 04 Aug 2012
4. Butler SL, Valdez H, Westby M, Perros M, June CH, Jacobson JM, Levy Y, Cooper DA, Douek D, Lederman MM, Tebas P (2011) Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 58:297-303
5. Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW (2009) Progressive multifocal leukoencephalopathy complicating HIV-1 infection. Lancet Infect Dis 9:625-636
6. Dang X, Wüthrich C, Gordon J, Sawa H, Koralnik IJ (2012) JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One 7:e35793. doi: 10.1371/journal.pone.0035793
7. Falcò V, Olmo M, Villar del Saz S, Guelar A, Santos JR, Gutiérrez M, Colomer D, Deig E, Mateo G, Montero M, Pedrol E, Podzamczer D, Domingo P, Llibre JM (2008) Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr 49:26-31
8. Fedele CG, Ciardi MR, Delia S, Contreras G, Perez JL, De Oña M, Vidal E, Tenorio A (2003) Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy. J Neurovirol 9:551-558
9. Gheuens S, Ngo L, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ (2012) Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology 79:1041-1048
10. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, Hultin LE, Jamieson BD, Margolick JB, Rinaldo CR Jr, Phair JP, Detels R, Multicenter AIDS Cohort Study (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29:346-355
11. Harrison SD, Newsome RL, Skolasky JC, McArthur AN, Daniel M (2011) Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. J Neuroimmunol 238:81-86
12. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187:1534-1543
13. Koralnik IJ, BodenD MVX, Lord CI, Letvin NL (1999) JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52:253-260
14. Marshall LJ, Major EO (2010) Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol 5:404-417
15. Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, Simpson DM, Prosperi M, De Luca A, Koralnik IJ (2009) Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73:1551-1558
16. Mascarello M, Lanzafame M, Lattuada E, Concia E, Ferrari S (2011) Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART. J Neurovirol 17:196-199
17. Padgett BL, Zu Rhein GM, Walker DL, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1:1257-1260
18. Pietropaolo V, Videtta M, Fioriti D, Mischitelli M, Arancio A, Orsi N, Degener AM (2003) Rearrangement patterns of JC virus noncoding control region from different biological samples. J Neurovirol 9:603-611
19. Sabath BF, Major EO (2002) Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis 186(Suppl 2):S180-S186
20. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL (2007) Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117:3148-3154
21. Sloan RD, Wainberg MA (2011) The role of unintegrated DNA in HIV infection. Retrovirology 8:52
22. Tan CS, Ellis LC, Wüthrich C, Ngo L, Broge TA Jr, Saint-Aubyn J, Miller JS, Koralnik IJ (2010) JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 84:9200-9209
23. Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72:1458-1464
24. White MK, Khalili K (2011) Pathogenesis of progressive multifocal leukoencephalopathy - revisited. J Infect Dis 203:578-586
25. Yogo Y, Iida T, Taguchi F, Kitamura T, Aso Y (1991) Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 29:2130-2138